Anderson-Fabry disease (OMIM 301500), or Fabry disease (FD), is an X-linked inherited metabolic condition characterized by a deficit in the activity of the α-galactosidase A enzyme, encoded by the GLA gene, which leads to glycosphingolipid storage, mainly globotriaosylceramide (Gb3) [1]. Here, GLA is linked to Fabry disease.